Hepatitis B prevalence using residual sera from febrile rash surveillance in South Africa in 2018
No Thumbnail Available
Date
2021
Authors
Cuamba, Inocência Augusto
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Hepatitis B is a significant public health issue caused by the hepatitis B virus. In 2017 there were
1.1 million new hepatitis B infections, most of them occurring in low and middle-income countries.
A viral hepatitis strategy has been developed whereby countries are required to have updated
information on the prevalence of hepatitis B and this data may be collected by ongoing
surveillance. In South Africa, there is no active surveillance for hepatitis B amongst asymptomatic
individuals in the general community. Therefore, in order to obtain estimates of the hepatitis B
burden in South African children we have used residual samples from the active febrile rash
surveillance conducted in 2018. We measured serological markers for hepatitis B. Of the included
children, 0.2% (2/1010) were positive for hepatitis B surface antigen. Immunity due to vaccination
was observed in 76% (770/1010) of the children. Of the analyzed samples 3% (30/1010) had
immunity due to previous exposure, 1.1% (11/1010) had evidence of previous exposure by the
presence of antibodies to hepatitis B core antigen and 20% (197/1010) had no evidence of previous
exposure to hepatitis B. The results suggest that the current prevalence of hepatitis B infection is
low in comparison to the period before implementation of hepatitis B immunization in South
Africa.
Description
A research report submitted in fulfilment of the requirements for the degree Masters of Science in Vaccinology to the Faculty of Health Sciences, School of Pathology, University of the Witwatersrand, Johannesburg, 2021